SEC Filing Summary for Phio Pharmaceuticals Corp.

Ronald Todd Plott, a director at Phio Pharmaceuticals Corp., reported the acquisition of 5,000 shares of common stock on September 28, 2026, at a price of $1.03 per share. This transaction increased his total holdings to 37,000 shares. Subsequently, on September 29, 2026, Plott acquired an additional 5,000 shares at $1.04 per share, bringing his total shares to 42,000. These transactions are marked as direct ownership. The shares acquired are stated to include those underlying unvested restricted stock units.